279 related articles for article (PubMed ID: 23098690)
1. 1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study.
Ferreira GB; Overbergh L; Verstuyf A; Mathieu C
J Steroid Biochem Mol Biol; 2013 Jul; 136():160-5. PubMed ID: 23098690
[TBL] [Abstract][Full Text] [Related]
2. A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes.
Ferreira GB; Baeke F; Verstuyf A; De Clercq P; Waelkens E; Mathieu C; Overbergh L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():96-101. PubMed ID: 24176759
[TBL] [Abstract][Full Text] [Related]
3. Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.
Van Etten E; Decallonne B; Verlinden L; Verstuyf A; Bouillon R; Mathieu C
J Cell Biochem; 2003 Feb; 88(2):223-6. PubMed ID: 12520518
[TBL] [Abstract][Full Text] [Related]
4. Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3).
van Halteren AG; van Etten E; de Jong EC; Bouillon R; Roep BO; Mathieu C
Diabetes; 2002 Jul; 51(7):2119-25. PubMed ID: 12086941
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D analog TX527 ameliorates disease symptoms in a chemically induced model of inflammatory bowel disease.
Verlinden L; Leyssens C; Beullens I; Marcelis S; Mathieu C; De Clercq P; Verstuyf A
J Steroid Biochem Mol Biol; 2013 Jul; 136():107-11. PubMed ID: 23000190
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.
Penna G; Adorini L
J Immunol; 2000 Mar; 164(5):2405-11. PubMed ID: 10679076
[TBL] [Abstract][Full Text] [Related]
8. 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis.
van Halteren AG; Tysma OM; van Etten E; Mathieu C; Roep BO
J Autoimmun; 2004 Nov; 23(3):233-9. PubMed ID: 15501394
[TBL] [Abstract][Full Text] [Related]
9. NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3.
van Etten E; Decallonne B; Bouillon R; Mathieu C
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):457-9. PubMed ID: 15225820
[TBL] [Abstract][Full Text] [Related]
10. A novel immunosuppressive 1alpha,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity.
Zügel U; Steinmeyer A; Giesen C; Asadullah K
J Invest Dermatol; 2002 Dec; 119(6):1434-42. PubMed ID: 12485451
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.
Griffin MD; Lutz W; Phan VA; Bachman LA; McKean DJ; Kumar R
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6800-5. PubMed ID: 11371626
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo.
Ferreira GB; van Etten E; Verstuyf A; Waer M; Overbergh L; Gysemans C; Mathieu C
Diabetes Metab Res Rev; 2011 Nov; 27(8):933-41. PubMed ID: 22069288
[TBL] [Abstract][Full Text] [Related]
15. Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D.
Ferreira GB; van Etten E; Lage K; Hansen DA; Moreau Y; Workman CT; Waer M; Verstuyf A; Waelkens E; Overbergh L; Mathieu C
Proteomics; 2009 Jul; 9(14):3752-64. PubMed ID: 19639594
[TBL] [Abstract][Full Text] [Related]
16. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
17. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 1alpha,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation.
Campbell MJ; Drayson MT; Durham J; Wallington L; Siu-Caldera ML; Reddy GS; Brown G
Mol Cell Endocrinol; 1999 Mar; 149(1-2):169-83. PubMed ID: 10375029
[TBL] [Abstract][Full Text] [Related]
19. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells.
Piemonti L; Monti P; Sironi M; Fraticelli P; Leone BE; Dal Cin E; Allavena P; Di Carlo V
J Immunol; 2000 May; 164(9):4443-51. PubMed ID: 10779743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
